JACOBS LEVY EQUITY MANAGEMENT, INC - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$182,000
-28.3%
37,646
+57.3%
0.00%0.0%
Q4 2019$254,000
-33.9%
23,929
-19.9%
0.00%
-66.7%
Q1 2019$384,000
-10.9%
29,864
-34.2%
0.01%
-25.0%
Q4 2018$431,000
-12.4%
45,413
+48.1%
0.01%0.0%
Q2 2018$492,000
+154.9%
30,656
+148.0%
0.01%
+166.7%
Q4 2017$193,000
+20.6%
12,360
-33.9%
0.00%0.0%
Q1 2017$160,000
-40.1%
18,700
-25.1%
0.00%
-40.0%
Q4 2016$267,000
-51.9%
24,954
-51.3%
0.01%
-50.0%
Q3 2016$555,000
+46.8%
51,243
-8.3%
0.01%
+25.0%
Q2 2016$378,000
+62.9%
55,854
+12.0%
0.01%
+60.0%
Q1 2016$232,000
+46.8%
49,860
+272.1%
0.01%
+66.7%
Q2 2015$158,00013,4000.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 1,471,518$23,618,0008.40%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 492,930$7,862,0003.02%
Consonance Capital Management LP 2,747,198$44,093,0002.84%
NEXTHERA CAPITAL LP 559,517$8,980,0001.39%
Eventide Asset Management 1,086,400$17,437,0000.72%
Virtus ETF Advisers LLC 45,850$736,0000.65%
KNOTT DAVID M 90,000$1,445,0000.54%
Polar Capital LLP 1,912,605$30,697,0000.18%
Artal Group S.A. 400,000$6,420,0000.14%
J. Goldman & Co LP 100,000$1,605,0000.08%
View complete list of STEMLINE THERAPEUTICS INC shareholders